Please try another search
FIT Biotech Oy operates as a clinical-stage biotech company. The company focuses on developing antibody gene delivery technologies and gene vaccines for cancer immunotherapy, and the prevention and treatment of infectious diseases, such as HIV and tuberculosis, as well as animal vaccines. The company develops and licenses its patented gene transport unit (GTU) vector technology for new-generation medical treatments. It also markets FIT-06, a GTU-based DNA vaccine, for the treatment of HIV patients. It has a research collaboration agreement with Avacta Group plc to develop gene therapies. FIT Biotech Oy was founded in 1995 and is based in Tampere, Finland.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review